About Protein disulfide-isomerase A2
Protein disulfide-isomerase A2 (PDIA2) is a protein
from Homo sapiens identified by UniProt accession
Q13087, 525 residues long.
MolForge cross-references it against 0 known binders and
89 disease associations.
Target properties
| Protein name | Protein disulfide-isomerase A2 |
| UniProt accession | Q13087 |
| Gene | PDIA2 |
| Organism | Homo sapiens |
| Length | 525 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (89)
Diseases linked to this target (Open Targets).
- mean corpuscular volume · score 0.22
- mean corpuscular hemoglobin · score 0.21
- cardiovascular disease · score 0.20
- body fat percentage · score 0.20
- mean corpuscular hemoglobin concentration · score 0.19
- body mass index · score 0.17
- blood pressure · score 0.14
- Bicuspid aortic valve · score 0.12
- body height · score 0.11
- hypertension · score 0.09
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13087-F1 | alphafold | PREDICTED | 86.70 | — |
Amino-acid sequence (525 residues)
MSRQLLPVLL LLLLRASCPW GQEQGARSPS EEPPEEEIPK EDGILVLSRH TLGLALREHP ALLVEFYAPW CGHCQALAPE YSKAAAVLAA ESMVVTLAKV DGPAQRELAE EFGVTEYPTL KFFRNGNRTH PEEYTGPRDA EGIAEWLRRR VGPSAMRLED EAAAQALIGG RDLVVIGFFQ DLQDEDVATF LALAQDALDM TFGLTDRPRL FQQFGLTKDT VVLFKKFDEG RADFPVDEEL GLDLGDLSRF LVTHSMRLVT EFNSQTSAKI FAARILNHLL LFVNQTLAAH RELLAGFGEA APRFRGQVLF VVVDVAADNE HVLQYFGLKA EAAPTLRLVN LETTKKYAPV DGGPVTAASI TAFCHAVLNG QVKPYLLSQE IPPDWDQRPV KTLVGKNFEQ VAFDETKNVF VKFYAPWCTH CKEMAPAWEA LAEKYQDHED IIIAELDATA NELDAFAVHG FPTLKYFPAG PGRKVIEYKS TRDLETFSKF LDNGGVLPTE EPPEEPAAPF PEPPANSTMG SKEEL
Explore Protein disulfide-isomerase A2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets